» Articles » PMID: 33789923

Prognostic Predictors Relevant to End-of-life Palliative Care in Parkinson's Disease and Related Disorders: a Systematic Review

Overview
Date 2021 Apr 1
PMID 33789923
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease and related disorders (PDRD) are the second most common neurodegenerative disease and a leading cause of death. However, patients with PDRD receive less end-of-life palliative care (hospice) than other illnesses, including other neurologic illnesses. Identification of predictors of PDRD mortality may aid in increasing appropriate and timely referrals. To systematically review the literature for causes of death and predictors of mortality in PDRD to provide guidance regarding hospice/end-of-life palliative care referrals. We searched MEDLINE, PubMed, EMBASE and CINAHL databases (1970-2020) of original quantitative research using patient-level, provider-level or caregiver-level data from medical records, administrative data or survey responses associated with mortality, prognosis or cause of death in PDRD. Findings were reviewed by an International Working Group on PD and Palliative Care supported by the Parkinson's Foundation. Of 1183 research articles, 42 studies met our inclusion criteria. We found four main domains of factors associated with mortality in PDRD: (1) demographic and clinical markers (age, sex, body mass index and comorbid illnesses), (2) motor dysfunction and global disability, (3) falls and infections and (4) non-motor symptoms. We provide suggestions for consideration of timing of hospice/end-of-life palliative care referrals. Several clinical features of advancing disease may be useful in triggering end-of-life palliative/hospice referral. Prognostic studies focused on identifying when people with PDRD are nearing their final months of life are limited. There is further need for research in this area as well as policies that support need-based palliative care for the duration of PDRD.

Citing Articles

Nursing contribution to end-of-life care decision-making in patients with neurological diseases on an acute hospital ward: documentation of signs and symptoms.

Jonsdottir G, Vilhjalmsson R, Sigurdardottir V, Hjaltason H, Klinke M, Jonsdottir H BMC Nurs. 2025; 24(1):271.

PMID: 40069809 PMC: 11899557. DOI: 10.1186/s12912-025-02897-1.


Health care utilization at the end of life in Parkinson's disease: a population-based register study.

Leavy B, Akesson E, Lokk J, Schultz T, Strang P, Franzen E BMC Palliat Care. 2024; 23(1):251.

PMID: 39468712 PMC: 11520450. DOI: 10.1186/s12904-024-01581-6.


Care of the Patient Nearing the End of Life in the Neurointensive Care Unit.

Ramsburg H, Fischer A, Greenle M, Fehnel C Neurocrit Care. 2024; 41(3):749-759.

PMID: 39103717 PMC: 11599398. DOI: 10.1007/s12028-024-02064-5.


Gender-Specific Differences in Spinal Alignment and Muscle Power in Patients with Parkinson's Disease.

Bissolotti L, Rota M, Calza S, Romero-Morales C, Alonso-Perez J, Lopez-Bueno R Diagnostics (Basel). 2024; 14(11).

PMID: 38893669 PMC: 11171582. DOI: 10.3390/diagnostics14111143.


Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis.

Isaacson S, Pahwa R, Pagan F, Abler V, Truong D Clin Park Relat Disord. 2024; 10:100256.

PMID: 38770047 PMC: 11103413. DOI: 10.1016/j.prdoa.2024.100256.


References
1.
Manabe T, Mizukami K, Akatsu H, Hashizume Y, Teramoto S, Nakamura S . Prognostic Factors Related to Dementia with Lewy Bodies Complicated with Pneumonia: An Autopsy Study. Intern Med. 2016; 55(19):2771-2776. PMC: 5088536. DOI: 10.2169/internalmedicine.55.6868. View

2.
OSullivan S, Massey L, Williams D, Silveira-Moriyama L, Kempster P, Holton J . Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain. 2008; 131(Pt 5):1362-72. DOI: 10.1093/brain/awn065. View

3.
Mantri S, Fullard M, Beck J, Willis A . State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease. NPJ Parkinsons Dis. 2019; 5:1. PMC: 6345811. DOI: 10.1038/s41531-019-0074-8. View

4.
Snell K, Pennington S, Lee M, Walker R . The place of death in Parkinson's disease. Age Ageing. 2009; 38(5):617-9. DOI: 10.1093/ageing/afp123. View

5.
Teno J, Plotzke M, Gozalo P, Mor V . A national study of live discharges from hospice. J Palliat Med. 2014; 17(10):1121-7. DOI: 10.1089/jpm.2013.0595. View